drugset / Trial / NCT06816043
A Study of Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) and MK-8527 in Healthy Participants
RandomizedCrossoverOpen-labelBasic science
Summary
The goal of this study is to learn what happens to MK-8527 in a healthy person's body over time, called a pharmacokinetic (PK) study. Researchers want to learn if there is a difference in the healthy person's body when MK-8527 is taken as a single dose (Treatment A) or with the medication Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) (Treatment B).
Timeline
- Start
- 2025-02-21
- Primary completion
- 2025-06-05
- Completion
- 2025-06-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FTC/TDF | Unknown | — | Oral |
| Subject | MK-8527 | Small molecule | — | Oral |
Indications
No indication recorded.